Tobramycin - AlphaRx

Drug Profile

Tobramycin - AlphaRx

Alternative Names: Gentamicin nanoparticles - AlphaRx; Ocusolin; Ophthalmic gentamicin solution - AlphaRx; Zysolin

Latest Information Update: 23 Sep 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AlphaRx
  • Class Aminoglycosides; Antibacterials; Small molecules
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Nosocomial pneumonia; Ophthalmic infections; Sepsis

Most Recent Events

  • 05 Jul 2011 Discontinued - Preclinical for Nosocomial pneumonia in Canada (Inhalation)
  • 23 Jul 2009 Pharmacodynamics data from a preclinical trial in Nosocomial pneumonia released by AlphaRx
  • 05 Jun 2008 Discontinued - Preclinical for Ophthalmic infections in Canada (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top